Evidence map›Paper›PMID 24856929›Full record

ArticleCell metabolism2014

Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue.

Hui Gao, Niklas Mejhert, Jackie A Fretz, Erik Arner, Silvia Lorente-Cebrián, Anna Ehrlund, Karin Dahlman-Wright, Xiaowei Gong, Staffan Strömblad, Iyadh Douagi and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Nutrients · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Transcriptome Analyses of Adipose Tissue Samples IdentifyInternational journal of molecular sciences · 2022
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Hui GaoDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Niklas MejhertDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Jackie A FretzDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT 06520, USA.
Erik ArnerDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden; RIKEN Center for Life Science Technologies (Division of Genomic Technologies), RIKEN Yokohama Institute, Yokohama, Kanagawa, 230-0045, Japan.
Silvia Lorente-CebriánDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Anna EhrlundDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Karin Dahlman-WrightDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SE-141 86, Sweden; Science for Life Laboratory, Solna, SE-171 21, Sweden.
Xiaowei GongDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Staffan StrömbladDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Iyadh DouagiDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Jurga LaurencikieneDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Ingrid DahlmanDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Carsten O DaubDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SE-141 86, Sweden; RIKEN Center for Life Science Technologies (Division of Genomic Technologies), RIKEN Yokohama Institute, Yokohama, Kanagawa, 230-0045, Japan.
Mikael RydénDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Mark C HorowitzDepartment of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: mark.horowitz@yale.edu.
Peter ArnerDepartment of Medicine (H7), Karolinska Institutet, Stockholm, SE-141 86, Sweden. Electronic address: peter.arner@ki.se.
Karolinska Institutet · SEYale University · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy BalanceR24DK092759 · NIDDK · MAINEHEALTH · PI HOROWITZ, MARK C, MACDOUGALD, ORMOND A · 2011 to 2019
$13.0M
YALE CORE CENTER FOR MUSCULOSKELETAL DISORDERSP30AR046032 · NIAMS · YALE UNIVERSITY · PI INSOGNA, KARL LEONARD · 1999 to 2013
$9.0M
CONTROL OF OSTEOGENESIS AND ADIPOGENESIS BY EBFR01AR052690 · NIAMS · YALE UNIVERSITY · PI HOROWITZ, MARK C · 2007 to 2010
$1.3M
Regulation of Podocyte Differentiation by the Transcription Factor EBF1K99DK093711 · NIDDK · YALE UNIVERSITY · PI FRETZ, JACKIE · 2012 to 2013
$180k
NIAMS NIH HHS P30 AR046032NIAMS NIH HHS P30AR046032;NIAMS NIH HHS R01 AR052690NIAMS NIH HHS R01AR052690NIDDK NIH HHS 1K99DK093711NIDDK NIH HHS K99 DK093711NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30DK045735NIDDK NIH HHS R24 DK092759NIDDK NIH HHS R24DK092759
6 · The paper itself

Abstract

White adipose tissue (WAT) morphology characterized by hypertrophy (i.e., fewer but larger adipocytes) associates with increased adipose inflammation, lipolysis, insulin resistance, and risk of diabetes. However, the causal relationships and the mechanisms controlling WAT morphology are unclear. Herein, we identified EBF1 as an adipocyte-expressed transcription factor with decreased expression/activity in WAT hypertrophy. In human adipocytes, the regulatory targets of EBF1 were enriched for genes controlling lipolysis and adipocyte morphology/differentiation, and in both humans and murine models, reduced EBF1 levels associated with increased lipolysis and adipose hypertrophy. Although EBF1 did not affect adipose inflammation, TNFα reduced EBF1 gene expression. High-fat diet intervention in Ebf1(+/-) mice resulted in more pronounced WAT hypertrophy and attenuated insulin sensitivity compared with wild-type littermate controls. We conclude that EBF1 is an important regulator of adipose morphology and fat cell lipolysis and may constitute a link between WAT inflammation, altered lipid metabolism, adipose hypertrophy, and insulin resistance.

Indexed as

AdipocytesAdipogenesisAdipose Tissue, WhiteAdiposityAnimalsCells, CulturedDiabetes MellitusDiet, High-FatFemaleGene ExpressionHumansHypertrophyInflammationInsulin ResistanceLipolysisMaleEBF1 protein, humanRNA, Small InterferingTrans-ActivatorsTumor Necrosis Factor-alpha

Identifiers

PMID24856929
PMCPMC4109056
OpenAlexW2168459641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.